Theriva Biologics (TOVX) Prepaid Assets (2010 - 2026)
Theriva Biologics (TOVX) posted quarterly Prepaid Assets of $630000.0 for Q1 2026, up 150.0% year-over-year from $252000.0 in Q1 2025, and up 80.0% quarter-over-quarter from $350000.0 in Q4 2025.
Theriva Biologics (TOVX) Prepaid Assets (2010 - 2026) Analysis & Trends
Theriva Biologics (TOVX) has reported Prepaid Assets for 17 consecutive years, with $630000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Prepaid Assets rose 150.0% year-over-year to $630000.0; the TTM figure through Mar 2026 stood at $630000.0 (up 150.0% YoY), while the FY2025 annual figure was $350000.0, down 75.76% from the prior year.
- Prepaid Assets improved to $630000.0 in Q1 2026 per TOVX's latest filing, from $350000.0 in the prior quarter.
- Across five years, Prepaid Assets topped out at $3.7 million in Q4 2022 and bottomed at $84000.0 in Q3 2025.
- Historically, Prepaid Assets has averaged $968470.6 across 5 years, with a median of $350000.0 in 2025.
- Annual changes were most pronounced in 2022 — Prepaid Assets soared 836.43% — and 2023, when it slumped 94.91%.
- Theriva Biologics' Prepaid Assets stood at $3.7 million in 2022, then tumbled by 86.72% to $496000.0 in 2023, then surged by 191.13% to $1.4 million in 2024, then tumbled by 75.76% to $350000.0 in 2025, then soared by 80.0% to $630000.0 in 2026.
- Business Quant data shows TOVX's Prepaid Assets at $630000.0 in Q1 2026, $350000.0 in Q4 2025, and $84000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Theriva Biologics | 10.64 Mn | 10.64 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 653,000.00 |
| Mar 31, 2026 | 630,000.00 |
| Dec 31, 2025 | 350,000.00 |
| Sep 30, 2025 | 84,000.00 |
| Jun 30, 2025 | 208,000.00 |
| Mar 31, 2025 | 252,000.00 |
| Dec 31, 2024 | 1.44 Mn |
| Sep 30, 2024 | 95,000.00 |
| Jun 30, 2024 | 233,000.00 |
| Mar 31, 2024 | 337,000.00 |
| Dec 31, 2023 | 496,000.00 |
| Sep 30, 2023 | 114,000.00 |
| Jun 30, 2023 | 321,000.00 |
| Mar 31, 2023 | 440,000.00 |
| Dec 31, 2022 | 3.73 Mn |
| Sep 30, 2022 | 2.24 Mn |
| Jun 30, 2022 | 2.62 Mn |
| Mar 31, 2022 | 2.86 Mn |
| Dec 31, 2021 | 803,000.00 |
| Sep 30, 2021 | 1.42 Mn |